Poultry order issued over bird flu risk to be lifted
The order was introduced in February due to the heightened risk of bird flu.
The housing order will be revoked on 10 May.
While no outbreaks of a highly infectious bird flu strain have been detected in poultry in Ireland last year or this year, there were three outbreaks on commercial poultry farms in the North and one in captive birds there.
19 wild birds tested positive for bird flu in Ireland during the first three months of the year.
Minister for Agriculture, Food and the Marine Martin Heydon said that "the risk of avian influenza to our poultry is no longer as high as it had been in recent months, so it is now appropriate to lift the housing order and prohibition on the assembly of live birds.
He said: "I want to acknowledge the hard work and cooperation from the Irish poultry industry in recent months, with farmers, vets, processors and others all working together to reduce the chances of an outbreak which could have had such serious consequences.
"It is important to note that avian influenza is still a risk and will remain a threat to Irish poultry for the foreseeable future."
Despite the lifting of the housing order, strict biosecurity regulations for poultry farms that were introduced last December remain in place.
Members of the public are advised not to handle sick or dead wild birds and to report any such incidents to their Regional Veterinary Office or, if outside business hours, to contact the National Disease Emergency Hotline on 01 492 8026 or use the Department's Avian Check App.
Bird flu poses a low risk to humans and means foods such as eggs and chicken are still safe to eat, so long as they are properly cooked and prepared as normal.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
5 hours ago
- RTÉ News
Parents call on HSE to make breakthrough peanut allergy treatment available
Parents of children with severe peanut allergies are calling on the HSE to make a breakthrough treatment available in Ireland. Palforzia is a medicine for treating peanut allergy in children from one to 17 years of age. It has been authorised for use in the EU by the European Medicines Agency, but currently there is no planned timeline to roll it out in Ireland. It works by gradually exposing children to higher doses of peanut to help lower the risk of severe reactions, including anaphylaxis. This method is called oral immunotherapy. There are more than 20,000 children in Ireland living with a severe peanut allergy. The current approach is to avoid peanuts in the diet and carry emergency medication in case they are eaten. Some parents are now taking their children, at their own expense, to the UK, US or other European countries to access the Palforzia treatment. Catherine Dolan, from Greystones in Co Wicklow, is among a group of parents who want the HSE to make Palforzia available here. Her six-year-old son has a severe peanut allergy that puts him at risk of anaphylaxis. Ms Dolan said it creates a great deal of anxiety as the family navigates daily interactions. She has considered accessing the treatment abroad but said the logistics are difficult. "We've always had healthcare in our own country, and it does pose a risk when you go outside of the Irish system. I would consider it, we are talking about it, but I'd be really, really cautious about it," she said. Ms Dolan said she feels it is unacceptable that the treatment is available under the NHS in the UK, and other European countries, but not here. "We need to know when, and why. It has to happen. I'm balanced in my view - I know the healthcare system is really stretched, but I know the consultants are there, the care is there, and the expertise is there. We just need a national plan now to roll it out," she said. The HSE said it makes decisions on which medicines are reimbursed by the taxpayer on "objective, scientific and economic grounds". In November 2023, the National Centre for Pharmacoeconomics made a recommendation to the HSE that Palforzia "not be considered for reimbursement unless cost-effectiveness can be improved relative to existing treatments". Professor of Paediatrics and Child Health in the Royal College of Surgeons in Ireland and Children's Health Ireland Dr Jonathan Hourihane said cost-effectiveness of medicines is usually calculated based on whether the amount of money needed to treat a condition can be recouped through demonstrated savings based on hospital bed use or emergency departments attendances. Dr Hourihane said this metric does not apply to peanut allergy. "This condition is a community-based disease characterised by anxiety and isolation, not by having to go to a hospital every two weeks. So, it's been unreasonably rejected. I think it's disappointing for us as a country, as a country that recruited children to get the licence for the product. And I think it's insulting to the families who have this condition," he said. Dr Hourihane said he attends international conferences and is told by allergy doctors that they are treating Irish children in the US, France, Italy and the UK, among others. He believes it is "a sign of desperation" that parents are willing to travel at their own expense for "care that they should be able to get locally". He added that Irish doctors are not supporting people to access treatment abroad because they are not involved in those programmes and cannot stand over them. Dr Hourihane said: "We are aware of children who've had to attend the emergency hospitals in Dublin having had allergic reactions during their treatment courses, and we don't know what they've reacted to because we're not involved. "So, I think it's putting doctors in allergy clinics in Ireland in a difficult position. They're having to treat children who are having complications of treatment being supervised remotely." Dr Hourihane believes the true impact of peanut allergies has been disregarded. He said: "It's not a trivial illness if you think your child might die tomorrow while you're at work. I think a fundamental problem with the way it's been evaluated is the impact hasn't been fully accepted in the way that families want it to be accepted. "As a clinician I find it frustrating and disappointing that the state-of-the-art treatments that we helped develop internationally [are not available here], and Ireland is a major international player in this area. We're now the laughing stock of the international allergy community." The HSE said the company that has applied to make Palforzia available through the HSE in Ireland has now paused the application until the end of this year. The HSE added that it "is committed to providing access to as many medicines as possible, in as timely a fashion as possible, from the resources available (provided) to it". "The HSE robustly assesses applications for pricing and reimbursement to make sure that it can stretch available resources as far as possible and to deliver the best value in relation to each medicine and ultimately more medicines to Irish citizens and patients," it said.
The Irish Sun
13 hours ago
- The Irish Sun
The subtle symptom of new Covid-19 variant as cases soar in Ireland & public told to keep eye out
IRISH people are being warned to watch out for a subtle symptom of the latest Covid-19 variant as cases surge. But this variant comes with easy-to-miss signs - therefore leading to a quicker spread in the population. During the past week, there have been 477 new This is a stark rise from the 302 cases reported during the previous week. The XFG variant, which is also known as Stratus, is being attributed by health experts to the surge. Latest figures from Ireland's Health Protection Surveillance Centre (HPSC) shows an increase in Covid cases associated with the XFG variant. READ MORE IN HEALTH It has soared from 16.3 per cent to 40.9 per cent in only two weeks. As a result, the The organisation is warning that it may spread more rapidly, even if it doesn't cause more severe illness. But the variant has an unusual symptom that may be easily missed. Most read in Health The new symptom comes in the form of a hoarse or raspy voice which often comes before the typical Covid symptoms. OTHER SIGNS As a result, this could lead to undetected transmission, according to the Irish Mirror. Dr Kaywaan Khan, a Harley Street GP and the founder of Hannah London Clinic, told Cosmopolitan The fever (high temperature - 38C or above) - including having chills dry cough fatigue (tiredness) loss or change to your sense of smell or taste – this could mean they're completely gone or just different to normal nasal congestion (runny or blocked nose) conjunctivitis (also known as red eye or pink eye) sore throat headache muscle or joint pain (aches and pains) different types of skin rash nausea or vomiting diarrhoea chills dizziness shortness of breath or breathing difficulties loss of appetite confusion pain or pressure in the chest. If you have any symptoms of You should also avoid contact with others - especially those who are more vulnerable to the illness. LISTERIA Meanwhile, over 200 ready-made meals and side dishes have been recalled from Irish shops The Food Safety Authority of Ireland And it emerged today that Nine cases of listeriosis have been confirmed in Ireland as of Tuesday, July 22. The infection can include mild flu-like symptoms or none at all, according to the Safefood says a person with a listeria infection can have fever, tiredness and headache. There can also be gastrointestinal symptoms such as nausea, vomiting and diarrhoea. However, in rare cases the infection can be more severe and cause serious complications. Some people are more vulnerable to Listeria monocytogenes infections, including The Health Protection Surveillance Centre says that in immunocompromised and elderly individuals, the infection can occasionally spread to the central nervous system causing meningitis and/or septicaemia, with symptoms such as headache, stiff neck, confusion, and loss of balance or convulsions. 1 Covid19 cases are rising in Ireland Credit: Getty Images - Getty
Irish Post
13 hours ago
- Irish Post
‘Huge milestone' as Irish medical aesthetics firm launches 80th clinic
THE Irish-founded Thérapie Clinic chain marked a milestone moment this month with the launch of its 80th clinic. Founded in Dublin in 2001 by Belfast-born Paul McGlade, the medical aesthetics firm has achieved global success in the years that have passed and now has clinics based across the globe. Since 2024 it has been run by McGlade's children, Katie and Philip McGlade, who are in place as President International and CEO respectively. This month the brand launched a new branch in Co. Cork. The Thérapie Clinic in Wilton Shopping Centre is the firm's 30th in Ireland and 80th worldwide. 'It's a huge milestone for Thérapie Clinic to open our 30th clinic in Ireland, and we're delighted that it's in Cork,' Philip McGlade said. 'We have built up an incredible customer base in Cork at our Opera Lane clinic and that customer base continues to grow,' he added. 'The demand for Thérapie in Cork is so high, that a second clinic is a must.' The firm has invested more than €500k on the new site, to build a 'state-of-the-art clinic that offers the same premium services we're known for—but in a brand new space', they explain. 'From laser hair removal to our most in-demand injectable treatments, including anti-wrinkle injections and polynucleotides, everything at our at our Wilton clinic is backed by the same medical expertise and exceptional care we're trusted for across the country.' See More: Cork, Ireland, Thérapie Clinic
